Publications by authors named "Rouzbeh Chegeni"

Claim this Profile
U
Ultrasensitive quantitation of FLT3-ITD mutation in patients with acute myeloid leukemia using ddPCR.
Amir Asri Kojabad, Rouzbeh Chegeni, Shaharbano Rostami, Farhad Zaker, Majid Safa

Mol Biol Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Skp2 enhances doxorubicin-induced cell death in B cell precursor acute lymphoblastic leukemia.
Rima Manafi Shabestari, Rouzbeh Chegeni, Mohammad Faranoush, Farhad Zaker, Majid Safa

Cell Biol Int· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of classic and alternative non-homologous end joining pathways in hematologic malignancies: targeting strategies for treatment.
Mohsen Valikhani, Elahe Rahimian, Seyed Esmaeil Ahmadi, Rouzbeh Chegeni, Majid Safa

Exp Hematol Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.
Seyed Esmaeil Ahmadi, Samira Rahimi, Bahman Zarandi, Rouzbeh Chegeni, Majid Safa

J Hematol Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.
Seyed Esmaeil Ahmadi, Samira Rahimi, Bahman Zarandi, Rouzbeh Chegeni, Majid Safa

J Hematol Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoints in hematologic malignancies: What made the immune cells and clinicians exhausted!
Abbas Hajifathali, Sayeh Parkhideh, Mohammad H Kazemi, Rouzbeh Chegeni, Elham Roshandel

J Cell Physiol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma levels of norepinephrine and expression levels of ß2-adrenergic receptor gene correlate with the incidence of acute graft-versus-host disease.
Zahra Momeni-Varposhti, Mohammad Hossein Kazemi, Mehdi Talebi, Rouzbeh Chegeni, Elham Roshandel

Med J Islam Repub Iran· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altering chromatin methylation patterns and the transcriptional network involved in regulation of hematopoietic stem cell fate.
Mohammad Shokouhian, Marziye Bagheri, Behzad Poopak, Rouzbeh Chegeni, Nader Davari

J Cell Physiol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of CRISPR/Cas9 gene editing in cellular therapies for lymphoid malignancies.
Maryam Mehravar, Elham Roshandel, Maryam Salimi, Rouzbeh Chegeni, Majid Gholizadeh

Immunol Lett· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of a poly-epitope candidate vaccine against Hepatitis B, C, and poliovirus in interaction with monocyte-derived dendritic cells: An ex-vivo study.
Armina Alagheband Bahrami, Mojgan Bandehpour, Bahram Kazemi, Mahmood Bozorgmehr, Nariman Mosaffa, Rouzbeh Chegeni

Hum Immunol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of ABO incompatibility on the outcome of allogeneic hematopoietic stem cell transplantation.
Sayeh Parkhideh, Rouzbeh Chegeni, Mahshid Mehdizadeh, Elham Roshandel, Farzaneh Tavakoli

Transfus Apher Sci· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of H3 histone methylation and colony formation in erythroid progenitors treated with thalidomide and sodium butyrate.
Ali Dehghani Fard, Saeid Kaviani, Mehrdad Noruzinia, Masoud Soleimani, Saeid Abroun, Rouzbeh Chegeni

Lab Hematol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional analysis of three recombinant A1-VWF domain mutants in comparison to wild type and plasma-derived VWF facilitates subtyping in type 2 von Willebrand disease.
Rouzbeh Chegeni, Linda Vickars, Emmanuel J Favaloro, David Lillicrap, Maha Othman

Thromb Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice.
Mohammad Qadura, Braden Waters, Erin Burnett, Rouzbeh Chegeni, Scott Bradshaw

Blood· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4+CD25+-dependent mechanism and by shifting cytokine production to favor a Th1 response.
Braden Waters, Mohammad Qadura, Erin Burnett, Rouzbeh Chegeni, Andrea Labelle

Blood· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular genetic testing of hemostasis and thrombosis in developing countries: achievements, hopes, and challenges.
Margareth Castro Ozelo, Roman Zapata Esp, Mohammad Qadura, Rouzbeh Chegeni, Maha Othman

Semin Thromb Hemost· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factor V mutations in Iranian patients with activated protein C resistance and venous thrombosis.
Rouzbeh Chegeni, Bahram Kazemi, Abbas Hajifathali, Aliakbar Pourfathollah, Ghasem Rastegar Lari

Thromb Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis